Shareholder Alert: The Ademi Firm Continues to Investigate Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders

Core Viewpoint - The Ademi Firm is investigating STAAR for potential breaches of fiduciary duty and other legal violations related to its transaction with Alcon Inc, where STAAR shareholders will receive $28 per share in cash, valuing the transaction at approximately $[1] Group 1 - The investigation by the Ademi Firm focuses on possible breaches of fiduciary duty by STAAR in its dealings with Alcon Inc [1] - Shareholders of STAAR are set to receive $28 per share in cash as part of the transaction [1] - The total valuation of the transaction is approximately $[1]